Stock VIRX VIRACTA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Viracta Therapeutics, Inc.

Equities

VIRX

US92765F1084

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
0.7 USD +1.43% Intraday chart for Viracta Therapeutics, Inc. -4.76% +22.81%
May. 30 Day One Biopharmaceuticals Sells Priority Review Voucher for $108 Million MT
May. 23 Oppenheimer Adjusts Price Target on Viracta Therapeutics to $11 From $13, Maintains Outperform Rating MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
VIRACTA THERAPEUTICS, INC.
Other Biotechnology & Medical Research
+1.43%-4.76%+22.81%-52.38% - 27.49M
Bearish
Neutral
Neutral

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. VIRX Stock
  4. Charts Viracta Therapeutics, Inc.
  5. Comparison Chart